CFC MDI transition proposed rule publication would allay patient fears, hearing told.
This article was originally published in The Tan Sheet
Executive Summary
CFC TRANSITION PROPOSED RULE FDA PUBLICATION BEFORE ADJOURNMENT of the current congressional session could allay patient fears about the gradual phase-out of metered dose inhalers containing chlorofluorocarbons, Joint Council of Allergy, Asthma & Immunology President-Elect Daniel Ein, MD, told a House Commerce/Health Subcommittee hearing May 6. "It seems to me that a lot of concern, and sometimes hysteria, that has been roiled up about this issue could go away very quickly if the FDA didn't postpone yet again its next step -- the proposed rulemaking," Ein suggested.